An Observational, Epidemiological Study on the Prevalence of Human Papillomavirus (HPV) Types in Women >= 18 Years of Age, in Egypt
- Women >= 18 years of age attending a clinic for gynaecological examination.
- Women who agree to provide a cervical sample for human papillomavirus testing.
- Written informed consent obtained from the subject.
- Referral for abnormal cervical sample at the current visit.
- Abundant menstrual bleeding or vaginal discharge not allowing appropriate screening
to be performed.
- History of hysterectomy.
- Known diagnosis of immunosuppression, or patient on immunosuppressives.
- Pregnant women.
- Having received one or more doses of HPV vaccine prior to participating in the study.
Type of Study:
Observational Model: Cohort, Time Perspective: Prospective
Occurrence of Human papillomavirus (HPV) DNA and of any of the HPV types among women undergoing cervical sample testing.
Outcome Time Frame:
Average timeframe: 12 months
GSK Clinical Trials
Egypt: Ministry of Health
- Human Papillomavirus Infection
- Papillomavirus Infections